Summit Therapeutics Inc. (SMMT)
NASDAQ·Healthcare·Biotechnology
$15.37
—
Mkt Cap $12.63B
Analyst Ratings
Buy
5
Hold
7
Sell
0
Price Target (26 analysts)
$26.86
Range $15.00 – $38.00
Implied Upside
+74.8%
Consensus $26.86 vs current $15.37
NASDAQ·Healthcare·Biotechnology
$15.37
—
Mkt Cap $12.63B
Buy
5
Hold
7
Sell
0
Price Target (26 analysts)
$26.86
Range $15.00 – $38.00
+74.8%
Consensus $26.86 vs current $15.37